The frequency and VEN-analysis of pharmacotherapy in children with ARVI in the healthcare institution of the Poltava region

Abstract

Acute respiratory viral infections (ARVI) are diseases that have important medico-social importance since they are associated with a wide distribution among the population, the risk of complications, reduced quality of life of patients, and high total cost of treatment. Aim. To assess the quality of pharmacotherapy: the frequency of prescribing drugs for children with ARVI in the healthcare institution of the Poltava region and the correspondence of drug prescriptions to clinical protocols for providing medical care and the State Formulary of Medicines of Ukraine (SFMU). Materials and methods. The quality assessment of pharmacotherapy of children with ARVI was performed using auxiliary clinical and economic methods – the frequency and formal VEN-analyses. Results. The main directions of pharmacotherapy of children with ARVI in one of the healthcare institution of the Poltava region correspond to the unified clinical protocol of the primary care for adults and children with ARVI and clinical protocols for pharmacotherapy of concomitant diseases. Using the formal VEN-analysis it has been determined that the majority of INN drugs prescribed are recommended by clinical protocols for pharmacotherapy of the main (ARVI) and associated diseases registered in patients, and are available in the SFMU (87.50 and 54.69 %, respectively). Conclusions. The formal VEN analysis has shown that the ARVI pharmacotherapy correction is needed in the healthcare institution of the Poltava region studied since a significant part of the INN drugs prescribed is absent in the SFMU (45.31 %) and in clinical protocols for the primary pharmacotherapy (ARVI) and associated diseases (17.19 %). In both medical and technological documents there are no 12.50 % of INNs prescribed. For them 11.74 % of funds (4808.81 UAH) were spent by parents of sick children; they were prescribed 8.74 % times (38 prescriptions) of the total number of prescriptions – 431.

Authors and Affiliations

O. V. Tkachоva, O. Ya. Mishchenko, T. I. Sheptak

Keywords

Related Articles

The dynamics of the antidepressant effect of atristamine in the repeated dose study

Taking into account the peculiarities of the clinical application of antidepressants, namely gradual development of a therapeutically significant effect and a considerable duration of courses of treatment, an important a...

Development of the analytical diagnostics of atomoxetine poisonings

Atomoxetine is one of the main drugs used for the treatment of attention-deficit/hyperactivity disorder. The drug has repeatedly been the cause of fatal poisonings. Data on atomoxetine determination in the biological mat...

The study of the pharmacological action of the dry extract from Prunus domestica fruits on the model of comorbid functional constipation in the combined alcoholic liver damage in rats

The search for the most effective hepatoprotective agents is a topical issue of modern medicine. As a rule, the plant raw material is a promising object for studying medicinal properties. Based on the literature data, we...

The scientific and practical substantiation of the therapeutic drug monitoring procedure: validation of the analytical method of valproic acid measurement

The need for careful therapeutic drug monitoring (TDM) arises for measurement of drugs with a narrow therapeutic index (NTIDs), as well as for assuring their safe and controlled replacement with generics. In particular,...

Изучение эмоционально-поведенческой реакции у крыс после введения новогаленового фитокомплекса побегов Ledum palustre

При изучении новых лекарственных средств следует проводить исследования их действия на центральную нервную систему, а именно установить седативное, снотворное и анксиолитическое действие средства. Результаты исследований...

Download PDF file
  • EP ID EP657952
  • DOI 10.24959/cphj.19.1495
  • Views 85
  • Downloads 0

How To Cite

O. V. Tkachоva, O. Ya. Mishchenko, T. I. Sheptak (2019). The frequency and VEN-analysis of pharmacotherapy in children with ARVI in the healthcare institution of the Poltava region. Клінічна фармація; Клиническая фармация, 23(2), 48-53. https://europub.co.uk./articles/-A-657952